These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 3496428

  • 1. Effect of barbiturate coma on glucose utilization in normal brain versus gliomas. Positron emission tomography studies.
    Blacklock JB, Oldfield EH, Di Chiro G, Tran D, Theodore W, Wright DC, Larson SM.
    J Neurosurg; 1987 Jul; 67(1):71-5. PubMed ID: 3496428
    [Abstract] [Full Text] [Related]

  • 2. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma.
    Oriuchi N, Tomiyoshi K, Inoue T, Ahmad K, Sarwar M, Tokunaga M, Suzuki H, Watanabe N, Hirano T, Horikoshi S, Shibasaki T, Tamura M, Endo K.
    J Nucl Med; 1996 Mar; 37(3):457-62. PubMed ID: 8772644
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG: analysis of the FDG lumped constant.
    Spence AM, Muzi M, Graham MM, O'Sullivan F, Krohn KA, Link JM, Lewellen TK, Lewellen B, Freeman SD, Berger MS, Ojemann GA.
    J Nucl Med; 1998 Mar; 39(3):440-8. PubMed ID: 9529289
    [Abstract] [Full Text] [Related]

  • 5. Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors.
    Weber W, Bartenstein P, Gross MW, Kinzel D, Daschner H, Feldmann HJ, Reidel G, Ziegler SI, Lumenta C, Molls M, Schwaiger M.
    J Nucl Med; 1997 May; 38(5):802-8. PubMed ID: 9170450
    [Abstract] [Full Text] [Related]

  • 6. Brain imaging of glucose utilization in cerebral tumors.
    Di Chiro G.
    Res Publ Assoc Res Nerv Ment Dis; 1985 May; 63():185-97. PubMed ID: 3875134
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Glucose consumption and rate constants for 18F-fluorodeoxyglucose in human gliomas.
    Ishikawa M, Kikuchi H, Nagata I, Yamagata S, Taki W, Yonekura Y, Nishizawa S, Iwasaki Y, Mukai T.
    Neurol Med Chir (Tokyo); 1990 Jun; 30(6):377-81. PubMed ID: 1700316
    [Abstract] [Full Text] [Related]

  • 9. Effects of hyperglycemia on FDG uptake in human brain and glioma.
    Ishizu K, Nishizawa S, Yonekura Y, Sadato N, Magata Y, Tamaki N, Tsuchida T, Okazawa H, Miyatake S, Ishikawa M.
    J Nucl Med; 1994 Jul; 35(7):1104-9. PubMed ID: 8014665
    [Abstract] [Full Text] [Related]

  • 10. Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography.
    Di Chiro G, DeLaPaz RL, Brooks RA, Sokoloff L, Kornblith PL, Smith BH, Patronas NJ, Kufta CV, Kessler RM, Johnston GS, Manning RG, Wolf AP.
    Neurology; 1982 Dec; 32(12):1323-9. PubMed ID: 6983044
    [Abstract] [Full Text] [Related]

  • 11. Perfusion and metabolism in predicting the survival of patients with cerebral gliomas.
    Mineura K, Sasajima T, Kowada M, Ogawa T, Hatazawa J, Shishido F, Uemura K.
    Cancer; 1994 May 01; 73(9):2386-94. PubMed ID: 8168042
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Changes in glucose uptake by malignant gliomas: preliminary study of prognostic significance.
    Rozental JM, Levine RL, Nickles RJ.
    J Neurooncol; 1991 Feb 01; 10(1):75-83. PubMed ID: 2022974
    [Abstract] [Full Text] [Related]

  • 14. Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose.
    Heiss WD, Pawlik G, Herholz K, Wagner R, Göldner H, Wienhard K.
    J Cereb Blood Flow Metab; 1984 Jun 01; 4(2):212-23. PubMed ID: 6609929
    [Abstract] [Full Text] [Related]

  • 15. In vivo imaging of glucose consumption and lactate concentration in human gliomas.
    Herholz K, Heindel W, Luyten PR, denHollander JA, Pietrzyk U, Voges J, Kugel H, Friedmann G, Heiss WD.
    Ann Neurol; 1992 Mar 01; 31(3):319-27. PubMed ID: 1637139
    [Abstract] [Full Text] [Related]

  • 16. [Regional cerebral glucose metabolism associated with ataxic gait--an FDG-PET activation study in patients with olivopontocerebellar atrophy].
    Mishina M, Senda M, Ohyama M, Ishii K, Kitamura S, Terashi A.
    Rinsho Shinkeigaku; 1995 Nov 01; 35(11):1199-204. PubMed ID: 8720328
    [Abstract] [Full Text] [Related]

  • 17. FDG transport and phosphorylation in human gliomas measured with dynamic PET.
    Herholz K, Rudolf J, Heiss WD.
    J Neurooncol; 1992 Feb 01; 12(2):159-65. PubMed ID: 1560262
    [Abstract] [Full Text] [Related]

  • 18. [In vivo measurements of regional cerebral hemocirculation and metabolism in gliomas using 15O and 18F-fluorodeoxyglucose positron emission tomography].
    Mineura K, Yasuda T, Kowada M, Shishido F, Ogawa T, Uemura K.
    No To Shinkei; 1986 Apr 01; 38(4):337-44. PubMed ID: 3013262
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET.
    Alger JR, Frank JA, Bizzi A, Fulham MJ, DeSouza BX, Duhaney MO, Inscoe SW, Black JL, van Zijl PC, Moonen CT.
    Radiology; 1990 Dec 01; 177(3):633-41. PubMed ID: 2243962
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.